Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression

Tafazzin—an acyltransferase—is involved in cardiolipin (CL) remodeling. CL is associated with mitochondrial function, structure and more recently with cell proliferation. Various tafazzin isoforms exist in humans. The role of these isoforms in cardiolipin remodeling is unknown. Aim of this study was to investigate if specific isoforms like Δ5 can restore the wild type phenotype with respect to CL composition, cellular proliferation and gene expression profile. In addition, we aimed to determine the molecular mechanism by which tafazzin can modulate gene expression by applying promoter analysis and (Ingenuity Pathway Analyis) IPA to genes regulated by TAZ-deficiency. Expression of Δ5 and rat full length TAZ in C6-TAZ- cells could fully restore CL composition and—as proven for Δ5—this is naturally associated with restoration of mitochondrial respiration. A similar restoration of CL-composition could not be observed after re-expression of an enzymatically dead full-length rat TAZ (H69L; TAZMut). Re-expression of only rat full length TAZ could restore proliferation rate. Surprisingly, the Δ5 variant failed to restore wild-type proliferation. Further, as expected, re-expression of the TAZMut variant completely failed to reverse the gene expression changes, whereas re-expression of the TAZ-FL variant largely did so and the Δ5 variant to somewhat less extent. Very likely TAZ-deficiency provokes substantial long-lasting changes in cellular lipid metabolism which contribute to changes in proliferation and gene expression, and are not or only very slowly reversible.

[1]  Aditi U. Gurkar,et al.  Lipids as Regulators of Cellular Senescence , 2022, Frontiers in Physiology.

[2]  E. Esposito,et al.  Potential Therapeutic Effects of PPAR Ligands in Glioblastoma , 2022, Cells.

[3]  M. Keller,et al.  The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin‐deficient cells , 2021, Journal of inherited metabolic disease.

[4]  W. Pu Experimental models of Barth syndrome , 2021, Journal of inherited metabolic disease.

[5]  A. Santoni,et al.  The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases , 2020, Biology.

[6]  E. Werner,et al.  Phospholipid Acyl Chain Diversity Controls the Tissue-Specific Assembly of Mitochondrial Cardiolipins. , 2020, Cell reports.

[7]  Vassilios J. Bezzerides,et al.  AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome , 2020, Circulation research.

[8]  M. Lalk,et al.  16HBE Cell Lipid Mediator Responses to Mono and Co-Infections with Respiratory Pathogens , 2020, Metabolites.

[9]  M. Keller,et al.  Fatty acyl availability modulates cardiolipin composition and alters mitochondrial function in HeLa cells , 2020, bioRxiv.

[10]  U. Lendeckel,et al.  Proliferation of C6 glioma cells requires the phospholipid remodeling enzyme tafazzin independent of cardiolipin composition. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[11]  Astrid Gall,et al.  Ensembl 2020 , 2019, Nucleic Acids Res..

[12]  Linden J Gearing,et al.  CiiiDER: A tool for predicting and analysing transcription factor binding sites , 2019, PloS one.

[13]  K. Koberna,et al.  Quantification of fixed adherent cells using a strong enhancer of the fluorescence of DNA dyes , 2019, Scientific Reports.

[14]  O. Otto,et al.  Tafazzin-dependent cardiolipin composition in C6 glioma cells correlates with changes in mitochondrial and cellular functions, and cellular proliferation. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[15]  Mieczysław Dutka,et al.  Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors , 2019, Inflammation Research.

[16]  S. Rizzoli,et al.  Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia , 2018, Cell reports.

[17]  U. Lendeckel,et al.  Effects of siRNA-dependent knock-down of cardiolipin synthase and tafazzin on mitochondria and proliferation of glioma cells. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[18]  Chao Sun,et al.  Hoxa5 Promotes Adipose Differentiation via Increasing DNA Methylation Level and Inhibiting PKA/HSL Signal Pathway in Mice , 2018, Cellular Physiology and Biochemistry.

[19]  F. Damiano,et al.  Oleic Acid and Hydroxytyrosol Inhibit Cholesterol and Fatty Acid Synthesis in C6 Glioma Cells , 2017, Oxidative medicine and cellular longevity.

[20]  Rugang Zhang,et al.  Epigenetic Basis of Cellular Senescence and Its Implications in Aging , 2017, Genes.

[21]  Yuan Zhang,et al.  Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis , 2017, PloS one.

[22]  A. Londoño-Vallejo,et al.  Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line , 2017, Cell Communication and Signaling.

[23]  G. Hatch,et al.  Impaired Cardiolipin Biosynthesis Prevents Hepatic Steatosis and Diet-Induced Obesity , 2016, Diabetes.

[24]  U. Lendeckel,et al.  The mitochondrial phospholipid cardiolipin is involved in the regulation of T-cell proliferation. , 2016, Biochimica et biophysica acta.

[25]  C. Hunte,et al.  Structure and function of mitochondrial complex I. , 2016, Biochimica et biophysica acta.

[26]  Angela C. M. Luyf,et al.  Defining functional classes of Barth syndrome mutation in humans. , 2016, Human molecular genetics.

[27]  M. Esteller,et al.  Arachidonic and oleic acid exert distinct effects on the DNA methylome , 2016, Epigenetics.

[28]  R. Epand,et al.  Roles of specific lipid species in the cell and their molecular mechanism. , 2016, Progress in lipid research.

[29]  M. L. Greenberg,et al.  Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function , 2016, Journal of Bioenergetics and Biomembranes.

[30]  W. Pathmasiri,et al.  Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function , 2016, PloS one.

[31]  M. Velarde,et al.  Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype. , 2016, Cell metabolism.

[32]  A. Goette,et al.  Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria. , 2015, International journal of cardiology.

[33]  M. Frohman Role of mitochondrial lipids in guiding fission and fusion , 2015, Journal of Molecular Medicine.

[34]  R. Kelley,et al.  Clinical laboratory studies in Barth Syndrome. , 2014, Molecular genetics and metabolism.

[35]  M. L. Greenberg,et al.  The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotype. , 2014, Chemistry and physics of lipids.

[36]  Xianlin Han,et al.  Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts. , 2013, American journal of physiology. Heart and circulatory physiology.

[37]  A. Goette,et al.  Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo. , 2013, International journal of cardiology.

[38]  B. Hammock,et al.  Aging, Estrogen Loss and Epoxyeicosatrienoic Acids (EETs) , 2013, PloS one.

[39]  E. Ortlund,et al.  Phospholipid – Driven gene regulation , 2013, FEBS letters.

[40]  M. Schlame Cardiolipin remodeling and the function of tafazzin. , 2013, Biochimica et biophysica acta.

[41]  M. Ashworth,et al.  Barth syndrome , 2013, Orphanet Journal of Rare Diseases.

[42]  J. Campisi Aging, cellular senescence, and cancer. , 2013, Annual review of physiology.

[43]  Giovanna Ambrosini,et al.  EPD and EPDnew, high-quality promoter resources in the next-generation sequencing era , 2012, Nucleic Acids Res..

[44]  N. Mitro,et al.  Linking epigenetics to lipid metabolism: Focus on histone deacetylases , 2012, Molecular membrane biology.

[45]  Qingbo Xu,et al.  8,9-Epoxyeicosatrienoic Acid Inhibits Antibody Production of B Lymphocytes in Mice , 2012, PloS one.

[46]  A. Goette,et al.  Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs , 2012, British journal of pharmacology.

[47]  R. Walther,et al.  Composition of molecular cardiolipin species correlates with proliferation of lymphocytes , 2012, Experimental biology and medicine.

[48]  Ying Xia,et al.  c-Jun, at the crossroad of the signaling network , 2011, Protein & Cell.

[49]  B. Brüne,et al.  Anti-inflammatory Role of Microsomal Prostaglandin E Synthase-1 in a Model of Neuroinflammation* , 2010, The Journal of Biological Chemistry.

[50]  Vasant Honavar,et al.  ANEXdb: an integrated animal ANnotation and microarray EXpression database , 2009, Mammalian Genome.

[51]  G. Hatch,et al.  Cardiolipin synthesis is required to support human cholesterol biosynthesis from palmitate upon serum removal in Hela cells. , 2009, Canadian journal of physiology and pharmacology.

[52]  H. Shin,et al.  Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics , 2009, Allergy, asthma & immunology research.

[53]  M. Schlame,et al.  Characterization of Tafazzin Splice Variants from Humans and Fruit Flies* , 2009, The Journal of Biological Chemistry.

[54]  L. Siculella,et al.  Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells Published, JLR Papers in Press, June 13, 2007. , 2007, Journal of Lipid Research.

[55]  J. Shyy,et al.  The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Vera Adam-Vizi,et al.  Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. , 2005, Antioxidants & redox signaling.

[57]  A. Pozzi,et al.  Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids* , 2005, Journal of Biological Chemistry.

[58]  Anthony M Flores,et al.  Enzyme association with PPARγ: evidence of a new role for 15-lipoxygenase type 2 , 2005 .

[59]  Kathy Pfeiffer,et al.  Cardiolipin Stabilizes Respiratory Chain Supercomplexes* , 2003, Journal of Biological Chemistry.

[60]  Ronald J A Wanders,et al.  Only One Splice Variant of the Human TAZ Gene Encodes a Functional Protein with a Role in Cardiolipin Metabolism* , 2003, Journal of Biological Chemistry.

[61]  W. Dowhan,et al.  Cardiolipin and apoptosis. , 2002, Biochimica et biophysica acta.

[62]  Eric F. Johnson,et al.  The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands* , 2002, The Journal of Biological Chemistry.

[63]  Marc J. Prindle,et al.  Phosphorylation of Pax2 by the c-Jun N-terminal Kinase and Enhanced Pax2-dependent Transcription Activation* , 2002, The Journal of Biological Chemistry.

[64]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[65]  M. Schlame,et al.  Biosynthesis, remodeling and turnover of mitochondrial cardiolipin. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[66]  P. Ježek,et al.  Mitochondrial phospholipase A2 activated by reactive oxygen species in heart mitochondria induces mild uncoupling. , 2010, Physiological research.

[67]  Vishal M. Gohil,et al.  Cellular functions of cardiolipin in yeast. , 2009, Biochimica et biophysica acta.